Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2021 | 2020 | 2016 | 2015
Number of items: 4.

2021

Zimmer, Philipp, Hillebrand, Philipp, Wolf, Florian, Joisten, Niklas ORCID: 0000-0002-9947-8746, Walzik, David, Hardt, Luca, Grossek, Anja, Hartig, Philipp, Kierdorf, Fiona, Belz, Maximilian, Tinschmann, Malina, Kiesl, David, Bloch, Wilhelm, Gross-Ophoff-Mueller, Carolin, Hallek, Michael, Boell, Boris, Oberste, Max and Elter, Thomas (2021). Impact of induction chemotherapy on objective and self-perceived cognitive performance in patients suffering from hematological disorders. Leuk. Lymphoma, 62 (10). S. 2526 - 2531. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

2020

Herling, Carmen D., Cymbalista, Florence, Gross-Ophoff-Mueller, Carolin, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Busch, Raymonde, Porcher, Raphael ORCID: 0000-0002-5277-4679, Cazin, Bruno, Dreyfus, Brigitte, Ibach, Stefan, Lepretre, Stephane, Fischer, Kirsten, Kaiser, Florian, Eichhorst, Barbara, Wentner, Clemens-Martin, Hoechstetter, Manuela A., Doehner, Hartmut, Leblond, Veronique, Kneba, Michael, Letestu, Remi, Boettcher, Sebastian, Stilgenbauer, Stephan, Hallek, Michael and Levy, Vincent (2020). Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial. Leukemia, 34 (8). S. 2038 - 2051. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

2016

Langerbeins, Petra, Gross-Ophoff-Mueller, Carolin and Herling, Carmen D. (2016). Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia. Oncol. Res. Treat., 39 (1-2). S. 18 - 24. BASEL: KARGER. ISSN 2296-5262

2015

Kovacs, Gabor, Bahlo, Jasmin, Kluth, Sandra, Cramer, Paula, Fink, Anna-Maria, Fischer, Kirsten, Gross-Ophoff-Mueller, Carolin, Langerbeins, Petra, Maurer, Christian, von Tresckow, Julia, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Hallek, Michael, Eichhorst, Barbara and Goede, Valentin (2015). Prognostic Impact and Risk Factors of Reducing Prescribed Doses of Fludarabine, Cyclophosphamide and Rituximab (FCR) during Frontline Treatment of Chronic Lymphocytic Leukemia (CLL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Fri May 3 10:13:03 2024 CEST.